Investigators found that denileukin diftitox, which targets the interleukin-2 receptor, achieves objective response rates in 44% of patients with cutaneous T-cell lymphoma, with a median duration ...

Phototherapy involves the use of ultraviolet light for the treatment of skin disease and many dermatologists have phototherapy units in their offices. With these units, ultraviolet light of ...

In contrast, however, T-cell lymphomas commonly manifest in the skin. In fact, cutaneous T-cell lymphoma is one of the most common subtypes of T-cell lymphoma. Cutaneous T-cell lymphomas (CTCL ...

German biotech 4SC has filed its oral HDAC inhibitor Kinselby with the EMA, hoping to provide a much-needed new therapy for patients with the rare cancer cutaneous T-Cell lymphoma (CTCL).

Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous T-cell lymphoma (CTCL) at the annual meeting of the European Organisation ...

July 22, 2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for ...

It attaches to CD20 proteins on lymphoma cells and to CD3 proteins ... 0.8% were Black or African American, and 5% were Hispanic or Latino. The study looked at complete response (CR), which ...

Penny stock Citius Pharmaceuticals Inc (NASDAQ:CTXR) secures FDA approval on Thursday for Lymphir (denileukin diftitox-cxdl) to treat relapsed or refractory cutaneous T-cell lymphoma (CTCL ...

CTCL is a class of non-Hodgkin's lymphoma (NHL), a type of cancer of the white blood cells that are an integral part of the immune system. Unlike most NHLs which generally involve B-cell ...

Leukemia red spots are an early warning sign of leukemia. Symptoms of non-Hodgkin's lymphoma may include painless swelling of one or more lymph nodes, night sweats, itching, and more. Doctors ...

Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous T-cell lymphoma (CTCL) at the annual meeting of the European Organisation for ...

utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active ...